-+ 0.00%
-+ 0.00%
-+ 0.00%

Basilea Pharmaceutica Posts Higher H1 Net Profit, Total Revenue

MT Newswires·08/18/2026 01:33:02
Listen to the news
01:33 AM EDT, 08/18/2026 (MT Newswires) -- Basilea Pharmaceutica (BSLN.SW) said Tuesday its net profit and total revenue for the first half jumped year over year. Net profit for the six months ended June 30 was 27.9 million francs, compared with 15.8 million francs earlier. EPS moved to 2.13 francs from 1.26 francs. The Swiss biopharmaceutical company's total revenue was 119.0 million francs, compared with 104.0 million francs a year ago. For full-year 2026, the company upgraded its yearly growth guidance to 15% from 10% for total revenue, and to 40% from 20% for operating profit.